Psychedelic-Assisted Therapy
Mind Medicine Australia Clinic and Centre of Excellence
Abbotsford, Melbourne, VIC, Australia
Australian clinical service — factual listing only, not affiliated, no CTA. See listing for a contact link.
Psilocybin and MDMA are legal in Australia only via the TGA's Authorised Prescriber pathway for specific conditions; recreational use remains illegal. Ketamine, breathwork, and integration therapy are legally available more broadly.
Since 1 July 2023, the Therapeutic Goods Administration (TGA) has permitted psilocybin (for treatment-resistant depression) and MDMA (for PTSD) to be prescribed only by psychiatrists individually approved under the TGA's Authorised Prescriber (AP) scheme. These substances remain otherwise unapproved and cannot be prescribed by GPs or accessed outside this pathway; recreational or non-clinical use remains illegal everywhere in Australia. A 2026 regulatory update relaxed the requirement that the authorised psychiatrist be physically present for the entire dosing session, intended to improve access in regional and rural areas. Ketamine is a registered medicine and is used off-label for treatment-resistant depression at some clinics (including public hospital services) via psychiatrist referral — a separate pathway from the TGA psilocybin/MDMA scheme. Breathwork involves no controlled substances and is legally available nationwide.
General information, not legal advice — always verify current law before travelling.
Access to clinical psychedelic-assisted therapy in Australia is narrow by design: only a small number of TGA Authorised Prescribers exist nationally, treatment is a multi-month structured protocol (not a single session), and it’s reserved for the two approved conditions. Ketamine treatment for depression is more widely available, including through some public hospital services, but is still referral-only and not a walk-in service. See our clinics directory for factually-listed, neutral-mode services in this category — we don’t display pricing or promotional content for these listings, in line with TGA advertising rules for prescription-only medicines.
Most Australian clinical services are concentrated in capital cities (particularly Melbourne and Sydney), so regional and rural patients may need to travel or rely on the increasing use of telehealth for the psychotherapy components of treatment. Costs and Medicare/funding assistance vary by clinic and by patient circumstances — always confirm directly with the specific service.
Indicative only — verify current pricing before booking.
| Item | Low (AUD) | High (AUD) | Notes |
|---|---|---|---|
| Psychedelic-assisted therapy course (MDMA/psilocybin, full protocol) | $8,730 | $23,090 | Reported range from one Melbourne clinic; funding assistance may be available via Medicare, NDIS, DVA, or clinic patient-support funds — confirm directly |
| Ketamine treatment course (public hospital pathway) | $0 | $0 | Publicly funded where eligible — psychiatrist referral required; strict eligibility criteria apply |
| Integration therapy session (single session) | $300 | $340 | Reported rate from one Sydney practitioner; Medicare rebate may apply with a GP Mental Health Care Plan |
Integration
Redfern, Sydney, NSW (also telehealth), Australia
Unclaimed listing
Psychedelic-Assisted Therapy
Abbotsford, Melbourne, VIC, Australia
Australian clinical service — factual listing only, not affiliated, no CTA. See listing for a contact link.
Ketamine Clinic
Multiple clinics — NSW, QLD, VIC, ACT, Australia
Australian clinical service — factual listing only, not affiliated, no CTA. See listing for a contact link.
Ketamine Clinic
Parkville, Melbourne, VIC, Australia
Australian clinical service — factual listing only, not affiliated, no CTA. See listing for a contact link.
Breathwork Retreats
Gymea Retreat, Uki (Byron Bay hinterland), NSW, Australia
Unclaimed listing
Breathwork Retreats
Byron Bay region, NSW, Australia
Unclaimed listing
Integration
Manly NSW + multi-site (also telehealth nationally), Australia
Unclaimed listing
No. Only psychiatrists individually authorised under the TGA's Authorised Prescriber scheme can prescribe psilocybin or MDMA for the approved conditions (treatment-resistant depression and PTSD respectively) — GPs cannot prescribe either, and there is no pathway to access them outside this clinical scheme.
No — ketamine is a separately registered medicine used off-label for depression, accessed via ordinary psychiatrist referral (including at some public hospitals), distinct from the Authorised Prescriber scheme that governs psilocybin and MDMA.
Breathwork involves no controlled substances and is legally available across Australia — it sits outside the regulatory questions that apply to psilocybin, MDMA, or ketamine, though it isn't risk-free for everyone and has its own screening considerations. See our breathwork guide.